Acute lymphoblastic leukaemia: open trials in China

168 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07919470
Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT
Trial Treatment · Peking University People's Hospital
Peking University People's Hospital, Beijing Lu Daopei Hematology Hospital, Hebei Yanda Lu Daopei Hospital, Nanfang Hospital, Southern Medical University, Beijing
Registry updated 2026-11-05
NCT07239323
In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
Trial Treatment · Phase 1 · Chongqing Precision Biotech Co., Ltd
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming
Registry updated 2026-11-04
NCT04016129
CAR-T Immunotherapy Targeting CD19- ALL
Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-11-02
NCT04033302
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies
Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-11-02
NCT05995028
Universal 4SCAR7U Targeting CD7-positive Malignancies
Trial Treatment · Phase 1 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-11-02
NCT07910708
GN001 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and B-Cell Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1 · Department of Hematology,Rheumatology and Immunology,Pu'er People's Hospital
The 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming · Pu'er People's Hospital, Pu'er
Registry updated 2026-11-02
NCT05579132
A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)
Trial Treatment · Phase 1/2 · MSD R&D (China) Co., Ltd.
West China Second University Hospital, Sichuan University (Site 0011), Chengdu · The Second Affiliated Hospital of Third Military Medical University (Site 0008), Chongqing · Southern Medical University Nanfang Hospital (Site 0004), Guangzhou · The Children's Hospital of Zhejiang University School of Medicine (Site 0009), Hangzhou · The First Hospital of Harbin (Site 0005), Harbin · The Second Hospital of Hebei Medical University (Site 0003), Shijiazhuang · Hematology Hospital of Chinese Academy of Medical Sciences (Site 0001), Tianjin · Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology (Site 0010), Wuhan · Tongji Hospital affiliated to Tongji Medical College of HUST (Site 0006), Wuhan · The Affiliated Hospital of Xuzhou Medical University (Site 0007), Xuzhou · Henan Cancer Hospital-hematology department (Site 0002), Zhengzhou
Registry updated 2026-10-30
NCT04807881
Phase Ib Clinical Study of Keynatinib
Trial Treatment · Phase 1 · Medolution Ltd.
Peking University Third Hospital, Beijing · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing · West China Hospital，Sichuan University, Chengdu · Fudan University Shanghai Cancer Center, Shanghai
Registry updated 2026-10-29
NCT07278882
Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL
Trial Treatment · Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, Tianjin
Registry updated 2026-10-20
NCT07159620
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Trial Treatment · Phase 2 · The First Affiliated Hospital of Soochow University
The First Affiliated Hospital of Soochow University, Suzhou
Registry updated 2026-10-16
NCT07109219
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · AstraZeneca
Guangzhou · Tianjin
Registry updated 2026-10-15
NCT07616089
Phase I Study of FXS0683 in the Treatment of Blood Tumors
Trial Treatment · Phase 1 · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), Tianjin
Registry updated 2026-10-14
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 1/2 · AstraZeneca
Changsha · Chengdu · Guangzhou · Hangzhou · Nanjing · Suzhou · Tianjin · Zhengzhou
Registry updated 2026-10-13
NCT07862010
Study of GI001 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and B-Cell Acute Lymphoblastic Leukemia
Trial Treatment · Early phase 1 · Hematology department of the 920th hospital
The 920th Hospital of Joint Logistics Support Force, PLA, Yunnan
Registry updated 2026-10-07
NCT07854652
BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1 · The First Affiliated Hospital of Soochow University
The First Affiliated Hospital of Soochow University, Suzhou
Registry updated 2026-10-02
NCT07838714
Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of Relapsed or Refractory Acute B-Cell Lymphoblastic Leukemia
Trial Treatment · Phase 1 · Ruijin Hospital
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Registry updated 2026-09-25
NCT07840976
Immunotargeted Therapy Plus Low-Dose Chemotherapy in Newly Diagnosed Adult Ph+ B-ALL
Trial Treatment · Phase 2 · Institute of Hematology & Blood Diseases Hospital, China
Chinese Academy of Medical Sciences Hospital of Hematology (Chinese Academy of Medical Sciences Institute of Hematology), Tianjin
Registry updated 2026-09-25
NCT07830238
SNC116 Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Trial Treatment · Early phase 1 · Shanghai Simnova Biotechnology Co.,Ltd.
First Hospital of Jilin University, Changchun
Registry updated 2026-09-21
NCT05334823
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
Trial Treatment · Phase 2 · Chongqing Precision Biotech Co., Ltd
Beijing Children's Hospital, Capital Medical University, Beijing · Beijing Gobroad Boren Hospital, Beijing · The Second Xiangya Hospital, Central South University, Changsha · West China Second University Hospital, Sichuan University, Chengdu · Children's Hospital of Chongqing Medical University, Chongqing · Children's Hospital, Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of Zhengzhou University, Henan · The First Affiliated Hospital of NanChang University, Nanchang · Jiangsu Province Hospital, Nanjing · Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing · Shenzhen Children's Hospital, Shenzhen · Children's Hospital of Soochow University, Suzhou · Institute Of Hematology&Blood Diseases Hospital,Chinese Academy Of Medicai Sciences, Tianjin · Xiehe Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan · Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan · Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Registry updated 2026-09-15
NCT07813208
Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival
Research · The Children's Hospital of Zhejiang University School of Medicine
The Children's Hospital of Zhejiang University School of Medicine, Hangzhou
Registry updated 2026-09-10
NCT07003737
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
Trial Treatment · First Affiliated Hospital of Zhejiang University
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Registry updated 2026-09-02
NCT07350863
U69-CART-Cells For R/R T-ALL
Trial Treatment · Phase 1 · The First Affiliated Hospital of Soochow University
The First Affiliated Hospital of Soochow University, Suzhou
Registry updated 2026-09-02
NCT05495035
Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL
Trial Treatment · Phase 1 · Institute of Hematology & Blood Diseases Hospital, China
The Second Affiliated Hospital Of Anhui Medical University, Hefei · Qilu Hospital of Shandong University, Jinan · Department of Hematology/Oncology, Shanghai Jiaotong University School of Medicine Affiliated Shanghai Children's Medical Center, Shanghai · Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin
Registry updated 2026-08-26
NCT07784309
A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies
Trial Treatment · Phase 1 · Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, Tianjin
Registry updated 2026-08-25
NCT06927466
A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
Trial Treatment · Phase 1 · Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Peking University People's Hospital, Beijing · Jiangxi Province pediatric hospital, Nanchang · The First Affiliated Hospital of NanChang University, Nanchang · Children's Hospital of Shanghai, Shanghai · Shanghai Children's Medical Center, Shanghai · Children's Hospital of Soochow University, Suzhou · Tongji Hospital, Wuhan · The affiliated hospital of xuzhou medical university, Xuzhou
Registry updated 2026-08-17

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error